Abstract:Based on a defining criterion of 10%, the angular and horizontal sites were clinically equivalent with respect to the magnitude of osseous resorption that occurred after periodontal surgery and maintenance.
“…The findings of this prospective study differ from those of two previous retrospective case‐control studies which reported no statistically significant differences in progressive bone loss between angular and horizontal bony sites in treated periodontitis patients . Both of these previous studies compared radiographic crestal alveolar bone levels on non‐standardized serial radiographs taken either prior to or immediately after periodontal therapy, and up to 16 years post‐treatment.…”
Section: Discussioncontrasting
confidence: 92%
“…The findings of this prospective study differ from those of two previous retrospective case-control studies which reported no statistically significant differences in progressive bone loss between angular and horizontal bony sites in treated periodontitis patients. 6,7 Both of these previous studies compared radiographic crestal alveolar bone levels on non-standardized serial radiographs taken either prior to 7 or immediately after 6 periodontal therapy, and up to 16 years post-treatment. In contrast, the present study examined the marginal alveolar bone morphology established at periodontal sites after at least 1 year post-treatment, since pre-treatment angular lesions often exhibit resolution over the first 6 to 8 months post-treatment and may not persist long term.…”
Section: Discussionmentioning
confidence: 99%
“…Untreated angular bony lesions show a higher risk of further loss of alveolar bone than untreated defects having a horizontal bone morphology . No similar risk difference has been reported to date for angular and horizontal bony defects of treated periodontal sites …”
Section: Introductionmentioning
confidence: 91%
“…5 No similar risk difference has been reported to date for angular and horizontal bony defects of treated periodontal sites. 6,7 The presence or absence of radiographic lamina dura at the alveolar crest has been used as a diagnostic marker for periodontal breakdown in humans 8 and dogs. 9 In a 36-month prospective study of 51 adults treated for periodontitis, Rams et al 10 found the baseline presence of radiographic crestal alveolar lamina dura to be positively associated with periodontal clinical stability, and negatively associated with periodontitis recurrence.…”
Post-treatment presence of angular bone morphology and periodontal probing depths ≥5 mm significantly increased risk of progressive periodontitis at posterior interproximal sites. Sites of all morphology and probing depth that displayed radiographic crestal lamina dura at post-treatment baseline exhibited clinical stability for ≥24 months.
“…The findings of this prospective study differ from those of two previous retrospective case‐control studies which reported no statistically significant differences in progressive bone loss between angular and horizontal bony sites in treated periodontitis patients . Both of these previous studies compared radiographic crestal alveolar bone levels on non‐standardized serial radiographs taken either prior to or immediately after periodontal therapy, and up to 16 years post‐treatment.…”
Section: Discussioncontrasting
confidence: 92%
“…The findings of this prospective study differ from those of two previous retrospective case-control studies which reported no statistically significant differences in progressive bone loss between angular and horizontal bony sites in treated periodontitis patients. 6,7 Both of these previous studies compared radiographic crestal alveolar bone levels on non-standardized serial radiographs taken either prior to 7 or immediately after 6 periodontal therapy, and up to 16 years post-treatment. In contrast, the present study examined the marginal alveolar bone morphology established at periodontal sites after at least 1 year post-treatment, since pre-treatment angular lesions often exhibit resolution over the first 6 to 8 months post-treatment and may not persist long term.…”
Section: Discussionmentioning
confidence: 99%
“…Untreated angular bony lesions show a higher risk of further loss of alveolar bone than untreated defects having a horizontal bone morphology . No similar risk difference has been reported to date for angular and horizontal bony defects of treated periodontal sites …”
Section: Introductionmentioning
confidence: 91%
“…5 No similar risk difference has been reported to date for angular and horizontal bony defects of treated periodontal sites. 6,7 The presence or absence of radiographic lamina dura at the alveolar crest has been used as a diagnostic marker for periodontal breakdown in humans 8 and dogs. 9 In a 36-month prospective study of 51 adults treated for periodontitis, Rams et al 10 found the baseline presence of radiographic crestal alveolar lamina dura to be positively associated with periodontal clinical stability, and negatively associated with periodontitis recurrence.…”
Post-treatment presence of angular bone morphology and periodontal probing depths ≥5 mm significantly increased risk of progressive periodontitis at posterior interproximal sites. Sites of all morphology and probing depth that displayed radiographic crestal lamina dura at post-treatment baseline exhibited clinical stability for ≥24 months.
“…Periodontitis is an infection of the periodontium that results in the loss of connective tissue attachment and alveolar bone (1). It is a multifactorial disease and, in most cases, shows a chronic progression (2).…”
This study provided evidence for the lack of a significant difference between the conventional method and the DIA tool for radiographic measurement of intrabony defects. However, digital analysis was significantly faster.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.